Among diabetic patients with silent myocardial ischaemia (SMI), those showing significant coronary stenosis have the worst prognosis [1] . Although the exercise stress test (EST) is quite well accepted as the first test for the screening of SMI, it is not a predictor of severity and/or extent of ischaemia or of significant coronary artery involvement. Therefore, in patients with SMI, an additional imaging test is undertaken as final proof of ischaemia [2] . The imaging test may also reveal the extent and severity of coronary artery disease (CAD), which allows the early identification of patients for whom revascularisation is appropriate [2] .
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Together with ST-segment depression, other parameters measured during exercise are evaluated to improve the predictive value for severity of CAD and the risk stratification in non-diabetic and diabetic subjects. Among these parameters, heart rate, with adjustment for ST-segment depression, is the best known [3] . Resting pulse pressure (RPP) is a strong predictor for cardiac events [4] . Increased large artery stiffness, a major determinant of RPP, is frequent in diabetes and may contribute to the development of CAD and ischaemia [5] . However, no data are currently available on the possible diagnostic usefulness of RPP for the detection of CAD in patients with type 2 diabetes.
This cross-sectional study evaluated the usefulness of RPP in predicting severe CAD in patients with type 2 diabetes and SMI.
The study design has been described in detail elsewhere [6] . Briefly, we recruited asymptomatic type 2 diabetic patients, without resting ECG signs of ischaemia, who were considered to be at "high risk" because of peripheral vascular disease (indicated by stenosis >40% at ultrasound Doppler) and/or two or more atherogenic factors (family history of myocardial infarction, smoking, urinary albumin excretion rate >20 μg/min, blood pressure >140/90 mmHg or antihypertensive therapy, dyslipidaemia [LDL cholesterol >3.36 mmol/L, HDL cholesterol <0.90 mmol/L for men and <1.16 mmol/L for women] and triglycerides >2.26 mmol/L or antidyslipidaemic therapy).
Exclusion criteria were symptoms and/or ECG signs of ischaemia, age above 70 years, claudication below 400 m and left bundle branch block on resting ECG.
SMI at EST was defined as horizontal or downsloping exercise-induced ST-segment depression being 1 mm or more at 0.08 s after J point, with no angina. CAD was defined as stenosis being 70% or higher in at least one major epicardial artery at angiography. In accordance with the Helsinki Declaration, all patients were informed about the aim, risks, procedures and possible benefits of the study, and they all gave their consent.
Among the 147 patients included in the study, 114 were EST negative (EST−) and 33 were EST positive (EST+) with asymptomatic ST-segment depression (i.e. had SMI). All 33 EST+ patients underwent coronary angiography. Angiography was also performed in 44 of the 114 EST− patients; the patients were randomly selected (using a table of random numbers). These patients showed no difference in clinical, metabolic and EST features compared with the 70 EST− patients who did not undergo angiography (data not shown). Twenty-three of the 33 patients with SMI (EST+) and eight of the 44 patients without SMI (EST−) had CAD. In the ten patients with SMI (EST+) who did not have CAD, small vessel disease and/or endothelial dysfunction might be the cause of myocardial hypoxia [7] , while the presence of an only moderately reduced flow reserve is likely to explain the absence of ischaemia in the eight EST− patients with CAD [8] . Among patients with SMI, RPP was higher in the 23 with CAD than in the ten without it (62±14 vs 49±15 mmHg, p=0.03). Diastolic BP (77±13 vs 88±13 mmHg, p=0.02) but not systolic BP (139± 17 vs 138±21 mmHg) differed in patients with and without CAD, indicating that the RPP increase observed in the former group was mostly due to a reduction in diastolic BP. In patients with SMI, an RPP of 60 mmHg or higher (median and mean of this group) was associated with CAD in two or more vessels (n=20; odds ratio [OR] adjusted for age, sex, duration of diabetes and peripheral vascular disease: 10.9 [95% CI: 1.1-99.0], p=0.04) and in two vessels of the left main coronary artery (n=14; OR adjusted for age, sex, duration of diabetes and peripheral vascular disease: 12.9 [95% CI: 1.5-95.1], p=0.02). Both associations remained significant (p<0.05) after further adjustments for maximal heart rate and heart rate reserve at EST, which are predictors of severe CAD in type 2 diabetic patients with SMI [3] .
RPP was not different between the 33 EST+ (i.e. with SMI) and the 114 EST− patients (58±15 vs 53±16 mmHg, p=0.12). In the 44 randomly selected patients who were EST negative and undergoing angiography, while the proportion with peripheral vascular disease and the proportion with a duration of diabetes longer than 10 years were higher in the eight patients with CAD (three with twoand five with one-vessel disease) than in the 36 patients without CAD, no difference in RPP was detected between these two groups (55±20 vs 50±15 mmHg, p=0.37).
Taken together these data suggest that RPP is only associated with CAD when SMI is also present. Conversely, RPP is not associated with SMI or with CAD when each of these conditions is singly present.
In conclusion, among asymptomatic "high-risk" type 2 diabetic patients with SMI (as detected by EST), RPP seems to be an independent and strong predictor of a more aggressive form of CAD. Further and more detailed studies will clarify whether RPP helps to detect patients who could directly receive angiography treatment for revascularisation with no need for an additional imaging test, thus reducing time and costs for diagnosis and intervention.
